A proteomic signature for dementia with Lewy bodies

INTRODUCTION: We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease would distinguish patients with Lewy body disease from normal controls, and if it would distinguish dementia with Lewy bodies (DLB) from Parkinson's disease (PD). METHODS: Stored pl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Alzheimers Dement (Amst)
Autori principali: O'Bryant, Sid E., Ferman, Tanis J., Zhang, Fan, Hall, James, Pedraza, Otto, Wszolek, Zbigniew K., Como, Tori, Julovich, David, Mattevada, Sravan, Johnson, Leigh A., Edwards, Melissa, Graff-Radford, Neill R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424013/
https://ncbi.nlm.nih.gov/pubmed/30923734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2019.01.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi